R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Weekly News Round-up – 1/4/21

3 weeks ago By Charlotte Di Salvo
  • Share on

  • Facebook
  • Linkedin

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech and Pfizer. 

GSK SUPPORTS NOVAVAX COVID 19 VACCINE MANUFACTURING – In collaboration with NOVAVAX and the UK’s Vaccines Task Force, GSK has agreed to support the manufacturing of up to 60 million COVID-19 vaccines. The recent partnership could increase production capacity and meet the April 15 deadline to offer a first dose to all over 50’s. 

AMGEN TO ACQUIRE RODEO THERAPEUTICS – Under a new agreement, Amgen Inc. will acquire Rodeo Therapeutics Corporation. The strategic move by Amgen seeks to collaborate with Rodeo’s enzyme programme (15-PGDH) to develop ‘first-in-class’ therapeutics alongside Amgen’s inflammation research. Any outstanding shares of Rodeo will be acquired by Amgen in exchange for an upfront payment of $55 million. 

2021 VACCINE TARGET BOOSTED BY BIONTECH-PFIZER – With further manufacturing capacity, expansion BioNTech and Pfizer could deliver 2.5 billion COVID-19 doses by 2022. The recent addition of BioNTech’s latest facility in Marburg, Germany, has resulted in expansion of the manufacturing and supply network to accelerate commercial production. 

R&D
IBM unveils next steps in AI technology with quantum computer

Clinical
First cell-based gene therapy approved for Adult Multiple Myeloma by FDA

Manufacturing 
Human error costs J&J 15 million COVID-19 vaccines

That’s all for now. See you next week!

Charlotte Di Salvo, Junior Medical Writer
Proventa International

More news

Preclinical Pharmacokinetics: Solving the Problems of Early-Stage Predictive Assays

Understanding the pharmacokinetic profile (PK) of a compound is critical in selecting appropriate drug candidates in preclinical studies. The challenge is to predict the PKs of compounds in humans using early-stage predictive assays in these studies. Innovations in the last...

20 hours ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Preclinical Pharmacokinetics: Solving the Problems of Early-Stage Predictive Assays

Understanding the pharmacokinetic profile (PK) of a compound is critical in selecting appropriate drug candidates in preclinical studies. The challenge is to predict the PKs of compounds in humans using early-stage predictive assays in these studies. Innovations in the last...

20 hours ago

Emerging therapeutic areas of clinical attention & investment opportunities

Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...

4 days ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Emerging therapeutic areas of clinical attention & investment opportunities

Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...

4 days ago

Weekly News Round-up – 16/4/21

In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...

4 days ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Weekly News Round-up – 16/4/21

In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...

4 days ago
Working With us

Interested?
Reserve your space